Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2260-2026

Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P Recall

Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P

FDA recall Class II

Ongoing

FDA lists this Class II recall for Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2260-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 10, 2026
FDA report date
Jun 3, 2026
Quantity in commerce
8 kits
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Medline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627P

Affected model & UDI checker

Search the exact identifiers published for Z-2260-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedMedline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627PCheck source notice10198459151569
Not specifiedMedline medical convenience kit labeled as EYE TRAY-LF, Medline Kit SKU DYNJ21627PCheck source notice40198459151560
FDA code information

UDI/DI 10198459151569 (each), 40198459151560 (case), Lot Numbers: 26BMC538

View the original FDA recall notice

Why was this product recalled?

Specific Medline Kits contain Cardinal Health Monoject 1mL Luer Lock Syringes, Tuberculin Print, Sterile. Cardinal Health has recalled these syringes because the outer carton and blister pack are labeled as a 1 mL Luer Lock Tuberculin Syringe (Product Code 1180100777), but the syringes inside are U-100 insulin syringes.

What actions did Medline Industries, LP take?

Medline Industries, LP issued an URGENT MEDICAL DEVICE RECALL notice to it consignees on 4/10/2026 via USPS first class mail and email. The notice explained the issue, potential risk, and requested the following: "REQUIRED ACTION: 1. Immediately check your stock for the affected item number(s) and the affected lot number(s) listed on the enclosed response form. Quarantine all affected product. 2. Please complete and return the enclosed response form listing the quantity of affected product you have in inventory. Even if you do not have any affected product in inventory, please complete and return the response form. 3. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. 4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please include your customers quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product." For questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology